Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan.
Int J Urol. 2024 Jun;31(6):599-606. doi: 10.1111/iju.15426. Epub 2024 Feb 17.
This review presents the latest insights on robot-assisted kidney autotransplantation (RAKAT). RAKAT is a minimally invasive surgical procedure and represents a promising alternative to conventional laparoscopic nephrectomy followed by open kidney transplantation for the treatment of various complex urological and vascular conditions. RAKAT can be performed either extracorporeally or intracorporeally. Additionally, a single-port approach can be performed through one small incision without the need to reposition the patient. Of 86 patients undergoing RAKAT, 8 (9.3%) developed postoperative > Grade 2 Clavien-Dindo (CD) complications. Although the feasibility of RAKAT was established in 2014, the long-term efficacy and safety along with outcomes of this surgical approach are still being evaluated, and additional studies are needed. With improvements in the technology of RAKAT and as surgeons gain more experience, RAKAT should become increasingly used and further refined, thereby leading to improved surgical outcomes and improved patients' quality of life.
这篇综述介绍了机器人辅助肾自体移植（RAKAT）的最新进展。RAKAT 是一种微创手术，代表了一种有前途的替代方法，可替代传统的腹腔镜肾切除术和开放性肾移植，用于治疗各种复杂的泌尿科和血管疾病。RAKAT 可以通过体外或体内进行。此外，还可以通过一个小切口进行单端口方法，而无需重新定位患者。在接受 RAKAT 的 86 名患者中，有 8 名（9.3%）发生了术后 > Clavien-Dindo（CD）分级 2 级的并发症。尽管 RAKAT 的可行性在 2014 年已经确立，但这种手术方法的长期疗效和安全性以及结果仍在评估中，还需要进一步的研究。随着 RAKAT 技术的改进以及外科医生经验的增加，RAKAT 的应用应该会越来越广泛，并进一步得到完善，从而改善手术结果和提高患者的生活质量。
